Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Monoclonal Antibody production

U.S. Department Of Agriculture·Maryland

Monoclonal Antibody production

Closes 11/12/2025$100k – $500kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The USDA, ARS, EEAVD is looking for procurement of Monoclonal antibody production for US H5 HPAI. The government anticipates awarding a Firm Fixed Price contract. Vendors must submit their quotes in accordance with FAR 52.212-2, including technical specifications and price. The technical aspects will be evaluated based on the ability to meet the minimum standards in the Performance Work Statement (PWS). • The quote must meet the minimum requirements of the PWS. • The quote must include a breakdown of the price for each element. • The quote must include descriptive literature or information showing that the quoted services meet all parts of the Statement of Work. • Electronic submissions are preferred. • Quotes must be received no later than Wednesday, November 12, 2025, at 4:00 PM Central Standard Time.

Attached files

Contact

Katelyn Nelson

[email protected]

(301) 837-8754

Key dates

Opened
11/5/2025
Questions due
11/7/2025
Closes
11/12/2025

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
1232SA26Q0007

Budget estimate

$100,000 – $500,000

The budget for this opportunity is not explicitly stated, but based on the fact that it is a firm fixed price contract for the production of Monoclonal antibodies, the budget could be in the range of $100,000 to $500,000. This estimate is based on the assumption that the production of Monoclonal antibodies is a complex and specialized process that requires significant resources and expertise. The actual budget could be higher or lower, depending on the specific requirements of the contract and the vendor's pricing.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Health And Human Services·United States of America

Top match · 62%

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

Department of Public Health·South Carolina

60% match

Sole Source Procurement for INSTI HIV‑1/HIV‑2 Antibody Test Kits and Controls

Rolling / TBD closeOpened 9/8/2026

U.S. Department Of Veterans Affairs·Texas

60% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. Department Of Veterans Affairs·California

60% match

6550--Blood Type IVD Reagents

Closes 11/16/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

60% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

59% match

Immune Drivers of Autoimmune Disease

Closes 6/10/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

59% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

59% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. Food and Drug Administration·United States of America

59% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Veterans Affairs·Missouri

59% match

AJ12--Development/Production - Kidney GEC-Specific AAV Vector

Closes 11/4/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

58% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Department Of Energy·New Mexico

58% match

TIDAL: Target-Induced Droplet Assembly of Ligands

Closes 12/8/2026Opened 9/8/2026

U.S. National Institutes of Health·United States of America

58% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. Department Of Veterans Affairs·New York

58% match

6640--LAB - Immunochemistry (IHC) STAIN system CPT

Closes 10/31/2026Opened 7/22/2026

U.S. National Institutes of Health·United States of America

58% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

58% match

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/18/2026

U.S. National Institutes of Health·United States of America

58% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. Department Of Energy·Ohio

58% match

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET

Closes 12/17/2026Opened 6/17/2026

U.S. National Institutes of Health·United States of America

58% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

58% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. Centers for Disease Control-GHC·United States of America

58% match

Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

Closes 3/13/2027Opened 8/31/2026

U.S. Department Of Health And Human Services·Maryland

57% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

57% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. Department Of Defense·Maryland

57% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 10/18/2024

U.S. National Institutes of Health·United States of America

57% match

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Closes 12/23/2027Opened 11/22/2024